Dimed S.A. Distribuidora De Medicamentos Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year, the company reported negative sales was BRL 50.86 million compared to BRL 42.69 million a year ago. Revenue was BRL 3,990.48 million compared to BRL 3,225.41 million a year ago. Net income was BRL 86.35 million compared to BRL 79.43 million a year ago. Basic earnings per share from continuing operations was BRL 0.58 compared to BRL 0.53 a year ago. Diluted earnings per share from continuing operations was BRL 0.58 compared to BRL 0.53 a year ago.